What is Medpace Holdings Inc's share price today?
Medpace Holdings Inc (MEDP) share price today is $653.73 as of November 5, 2026 at 8:26 PM IST. The stock touched a day high of $663.64 and a day low of $651.86.What exchange does Medpace Holdings Inc stock trade on, and under what ticker symbol?
Medpace Holdings Inc stock trades on NASDAQ under the ticker symbol MEDP.What is Medpace Holdings Inc's market capitalization?
Medpace Holdings Inc's market capitalization is $18.55B as of November 5, 2026 at 8:26 PM IST.What is Medpace Holdings Inc's price-to-earnings (P/E) ratio?
Medpace Holdings Inc's price-to-earnings (P/E) ratio is 36.84 as of November 5, 2026.What is Medpace Holdings Inc's price-to-book (P/B) ratio?
Medpace Holdings Inc's price-to-book (P/B) ratio is 30.98 as of November 5, 2026.Can Indian investors buy Medpace Holdings Inc shares?
Yes, You can buy Medpace Holdings Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Medpace Holdings Inc shares from India?
Indian investors can buy Medpace Holdings Inc shares in three steps: 1. Search Medpace Holdings Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Medpace Holdings Inc shares for Indian investors?
Since Medpace Holdings Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Medpace Holdings Inc shares via Tickertape?
Indian investors can start investing in Medpace Holdings Inc (MEDP) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0152 shares at the current price of $653.73.
$
₹
$653.730.46% (-3.03)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
36.84
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
30.98
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$18.01
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
3.32
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
18.24%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 14 analysts reports
Buy2 analysts
Hold11 analysts
Sell1 analyst
Price Upside
-0.83%
Earnings Growth
+20%
Rev. Growth
+12.62%
Company Profile
Company Profile
P/E Ratio
36.83
36.83
1Y Return
24.93%
24.93%
Buy Reco %
85.18
85.18
P/E Ratio
34.60
34.60
1Y Return
20.11%
20.11%
Buy Reco %
68.18
68.18
P/E Ratio
116.43
116.43
1Y Return
27.29%
27.29%
Buy Reco %
78.26
78.26
P/E Ratio
31.94
31.94
1Y Return
25.04%
25.04%
Buy Reco %
90.00
90.00
ILMN
P/E Ratio
41.00
41.00
1Y Return
103.84%
103.84%
Buy Reco %
47.61
47.61
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$656.77Baseline
Analyst Target - 1 year
Target$651.31-0.83%
All values in $
2026
Current$656.77Baseline
Analyst Target - 1 year
Target$651.31-0.83%
All values in $
Revenue Forecast
Revenue Forecast
Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.
The next fiscal year's mean estimate implies 12.62% growth, versus a trailing 3-year CAGR of 20.12%.
2025
Current$2.53Baseline
Forecast for Dec 2026
High$2.86+13.22%
Average$2.84+12.62%
Low$2.84+12.24%
All values in $ Billion
2025
Current$2.53Baseline
Forecast for Dec 2026
High$2.86+13.22%
Average$2.84+12.62%
Low$2.84+12.24%
All values in $ Billion
Earnings Per Share Forecast
Earnings Per Share Forecast
Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.
The next fiscal year's mean estimate implies 20.00% growth, versus a trailing 3-year CAGR of 27.51%.
2025
Current$15.3Baseline
Forecast for Dec 2026
High$18.92+23.66%
Average$18.36+20%
Low$18.11+18.37%
All values in $
2025
Current$15.3Baseline
Forecast for Dec 2026
High$18.92+23.66%
Average$18.36+20%
Low$18.11+18.37%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
| Financial Year | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 528.10 | 533.31 | 536.58 | 558.57 | 603.31 | 659.90 | 708.45 | 706.60 | 707.33 | 716 |
Gross Profit | 153.83 | 169 | 178.31 | 178.35 | 180.01 | 196.93 | 205.31 | 196.32 | 201.63 | 223.88 |
| Net Income | 88.35 | 96.42 | 117.01 | 114.59 | 90.26 | 111.13 | 135.13 | 123.87 | 121.36 | 137.46 |
| Net Profit Margin | 16.72% | 18.08% | 21.80% | 20.51% | 14.96% | 16.84% | 19.07% | 17.53% | 17.15% | 19.19% |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareDiagnostics & Research
HealthcareDiagnostics & Research
Valuation
Returns
Forecast
Compare valuation on Screener| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Medpace Holdings Inc | 36.84 | 30.98 | 3.32 |
| Thermo Fisher Scientific Inc | 36.83 | 4.61 | 1.99 |
| Agilent Technologies Inc | 34.60 | 6.58 | 1.45 |
Price Comparison
Price Comparison
Compare MEDP with any stock or ETFCompare MEDP with any stock or ETF
Comparing from
MEDP
TMO
A
The 12-month consensus target implies -0.83% growth, versus a trailing 3-year CAGR of 34.59%.